Fundraising Fox

Mike Berman

Investor

Consultant and Venture Partner at RiverVest Venture Partners

Tel Aviv, Israel

About

Michael Berman is a medical device investor and entrepreneur who has co-founded and led several companies in the sector. He co-founded Velocimed, which sold to St. Jude Medical in 2005 for $82.5M, and later co-founded and chaired both BridgePoint Medical (sold to Boston Scientific) and Rebiotix (sold to Ferring Pharmaceuticals). Earlier in his career he served as President of the Cardiology business at Boston Scientific from 1995 to 2000. He currently serves on the boards of 11 emerging medical device companies and holds BS and MBA degrees from Cornell University.

ContactΒ· published on Mike's own website

Invests in

Medical Devices

Beyond investing

Founded
Co-founded Velocimed, which was sold to St. Jude Medical in April 2005 for $82.5M. Co-founded and chaired BridgePoint Medical from 2005 to 2012, when it was sold to Boston Scientific. Co-founded and chaired Rebiotix from 2011 to 2018, when it was sold to Ferring Pharmaceuticals.
Education
Earned a BS from Cornell University in 1979. Earned an MBA from Cornell University in 1986.

From Mike's own website β€” common ground for a warm intro.

Experience

  1. RiverVest VenturesVenture Partnercurrent2014 β€” present
  2. Multiple Medical Device CompaniesBoard Membercurrent2000 β€” present
  3. RebiotixChairman2011 β€” 2018
  4. Boston Scientific CardiologyPresident1995 β€” 2000

Skills & more

Product Development34Marketing Strategy5Start-ups53Medical Devices99Leadership4Capital Equipment18Commercialization86Market Development64Healthcare7Strategy12Strategic Planning15Six Sigma2
+12 moreQuality AssuranceProduct LaunchDesign ControlBiotechnologyAngel InvestingCardiologyBusiness StrategyFDAManagementEntrepreneurshipCross-functional Team LeadershipLifesciences

From Mike's professional profile.

Investments

Board seats

CardiacSenseCardiosonicClearCut MedicalKedma SolarLutonixLutonix, Inc.Mazor RoboticsSTStentUltraShape inc.VenaCore/ToTAL

Investor

Velocimed, LLC

Sources: the investor's own website Β· the firm's website.

Colleagues at RiverVest Venture Partners

Frequently asked questions

Who is Mike Berman?
Michael Berman is a medical device investor and entrepreneur who has co-founded and led several companies in the sector. He co-founded Velocimed, which sold to St. Jude Medical in 2005 for $82.5M, and later co-founded and chaired both BridgePoint Medical (sold to Boston Scientific) and Rebiotix (sold to Ferring Pharmaceuticals). Earlier in his career he served as President of the Cardiology business at Boston Scientific from 1995 to 2000. He currently serves on the boards of 11 emerging medical device companies and holds BS and MBA degrees from Cornell University.
Where does Mike Berman work?
Mike Berman is Consultant and Venture Partner at RiverVest Venture Partners.
What does Mike Berman invest in?
Mike Berman invests in Medical Devices.
What boards does Mike Berman sit on?
Mike Berman holds tracked board seats at CardiacSense, Cardiosonic, ClearCut Medical, Kedma Solar, Lutonix, Lutonix, Inc., Mazor Robotics, STStent, UltraShape inc., VenaCore/ToTAL.
What companies has Mike Berman invested in?
Investments tracked here include Velocimed, LLC.
Where did Mike Berman go to school?
Mike Berman studied at Cornell University (MBA, Marketing).

Same school